Lincoln National Corp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,438	Closed	-$326K	–	1140
2024 Q1	$326K	Buy	+3,438	New	+$319K	0.01%	925
2023 Q3	–	Sell	-2,572	Closed	-$214K	–	1068
2023 Q2	$214K	Sell	2,572 -95	-4%	-$7.95K	﹤0.01%	940
2023 Q1	$203K	Sell	2,667 -524	-16%	-$43.5K	﹤0.01%	928
2022 Q4	$265K	Sell	3,191 -3,427	-52%	-$277K	0.01%	770
2022 Q3	$525K	Buy	6,618 +1,416	+27%	+$119K	0.01%	482
2022 Q2	$386K	Sell	5,202 -136	-3%	-$10.2K	0.01%	558
2022 Q1	$480K	Buy	5,338 +1,946	+57%	+$180K	0.01%	540
2021 Q4	$380K	Buy	3,392 +261	+8%	+$31.5K	0.01%	628
2021 Q3	$394K	Buy	3,131 +114	+4%	+$14.7K	0.01%	583
2021 Q2	$409K	Hold	3,017	–	–	0.01%	552
2021 Q1	$409K	Buy	3,017 +109	+4%	+$16.3K	0.01%	513
2020 Q4	$409K	Buy	2,908 +349	+14%	+$44.7K	0.01%	479
2020 Q3	$285K	Buy	2,559 +338	+15%	+$37.9K	0.01%	524
2020 Q2	$249K	Buy	+2,221	New	+$219K	0.01%	540
2020 Q1	–	Sell	-4,921	Closed	-$468K	–	679
2019 Q4	$468K	Buy	+4,921	New	+$426K	0.02%	410
2018 Q1	–	Sell	-2,442	Closed	-$207K	–	626
2017 Q4	$207K	Buy	+2,442	New	+$205K	0.01%	589
2017 Q3	–	Sell	-5,321	Closed	-$411K	–	416
2017 Q2	$411K	Buy	+5,321	New	+$377K	0.02%	218